DK1578774T3 - Oprensning af immunoglobuliner - Google Patents

Oprensning af immunoglobuliner

Info

Publication number
DK1578774T3
DK1578774T3 DK03754635.5T DK03754635T DK1578774T3 DK 1578774 T3 DK1578774 T3 DK 1578774T3 DK 03754635 T DK03754635 T DK 03754635T DK 1578774 T3 DK1578774 T3 DK 1578774T3
Authority
DK
Denmark
Prior art keywords
immunoglobulines
purification
Prior art date
Application number
DK03754635.5T
Other languages
English (en)
Inventor
Robin Fong
Meng Hong Heng
Original Assignee
Danisco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco Us Inc filed Critical Danisco Us Inc
Application granted granted Critical
Publication of DK1578774T3 publication Critical patent/DK1578774T3/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • B01D15/325Reversed phase
    • B01D15/327Reversed phase with hydrophobic interaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/20Partition-, reverse-phase or hydrophobic interaction chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03754635.5T 2002-09-18 2003-09-15 Oprensning af immunoglobuliner DK1578774T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41153702P 2002-09-18 2002-09-18
PCT/US2003/029103 WO2004026891A2 (en) 2002-09-18 2003-09-15 Protein purification

Publications (1)

Publication Number Publication Date
DK1578774T3 true DK1578774T3 (da) 2014-02-03

Family

ID=32030687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03754635.5T DK1578774T3 (da) 2002-09-18 2003-09-15 Oprensning af immunoglobuliner

Country Status (4)

Country Link
EP (1) EP1578774B1 (da)
AU (1) AU2003272454A1 (da)
DK (1) DK1578774T3 (da)
WO (1) WO2004026891A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0709726A2 (pt) 2006-04-05 2011-07-26 Abbott Biotechnology Ltd. purificaÇço de anticorpo
CN1908006B (zh) * 2006-08-07 2010-05-12 陈志南 一种快速纯化制备Fab片段抗体的工艺方法
SI2473617T1 (sl) * 2009-09-01 2020-07-31 F. Hoffmann-La Roche Ag Izboljšano prečiščevanje beljakovin z modificirano elucijo beljakovine A
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652348A (en) * 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
US20040018573A1 (en) * 2002-04-18 2004-01-29 Power Scott D Production of functional antibodies in filamentous fungi

Also Published As

Publication number Publication date
EP1578774A2 (en) 2005-09-28
EP1578774B1 (en) 2013-11-06
EP1578774A4 (en) 2010-08-04
WO2004026891A2 (en) 2004-04-01
AU2003272454A1 (en) 2004-04-08
WO2004026891A3 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1647529T3 (da) Fremgangsmåde til oprensing af spildevand
FR15C0028I2 (fr) Fabrication de tiacumicine
DK1476162T3 (da) Kontrolleret syntese af ziprasidone
DK1653807T3 (da) Anvendelse af dermale mikroorganer
DK1543038T4 (da) Proteinoprensning
IS7007A (is) Kristallaform af asiþrómýsíni
DK1587542T3 (da) Anvendelse af anti-CD100-antistoffer
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DK1501508T3 (da) Inhibitorer af histondeatylase
DK1532474T3 (da) Markering af rørforforbindelser
DK1578774T3 (da) Oprensning af immunoglobuliner
DK1546045T3 (da) Styring af spildevandsbehandlingsprocesser
DK1470732T3 (da) Fremskaffelse af lokaliseringsinformation
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
DK1516540T3 (da) Anvendelse af vitamin D-forbindelser
ATE364610T1 (de) Kristalline polymorphe form von irinotecan- hyrochlorid
DK1709075T3 (da) Behandling af virusinfektioner
DK1377544T3 (da) Oprensning af 2-nitro-4-methylsulfonylbenzoesyre
FR2841960B1 (fr) Bague de traversee de cloison
DK1400522T3 (da) Forbindelser til behandling af impotens
DK1631261T3 (da) Fremstilling af små partikler
DK1472412T3 (da) Byggesæt af brosten